R. Lampignano, M.H.D. Neumann, S. Weber, et al. have performed a comprehensive multicenter comparison of cell-free DNA preanalytical and analytical work flows—an important step toward establishing evidence-based guidelines for these work flows.
M.M. Mielke highlights the impetus to consider sex-based differences in the development and interpretation of clinical assays for Alzheimer’s disease and related disorders.
Metagenomic next-generation sequencing can offer hope for patients when traditional testing can’t find an answer.
SDI Productions / iStock
Researchers: Whole genome sequencing will overtake panel testing; infrastructure investments should start now to support this change.